LC
Lynx1 Capital Management LP
DORADO PR · SEC CIK 0001910456
$865.53M2026Q2 reported value
27Positions
98.8%Top 10 weight · largest 41.2%
6 / 2New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
GHRS Added+$67.20M
AGIO Added+$29.59M
PLIANT THERAPEUT New+$2.05M
CCCC Added+$1.53M
PROQR THRAPEUTIC Added+$842,444
2026Q2 top sells estimated at quarter-end value
DNLI Reduced-$48.06M
STOK Reduced-$23.73M
XNCR Reduced-$8.34M
IMTX Reduced-$1.96M
DSGN Sold out-$1.27M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| GHRS | GH RESEARCH PLC | $356.52M | 41.19% | 13,263,288 | 2,500,000 | 23.2% | $67.20M | Added |
| CGEM | CULLINAN THERAPEUTICS INC | $163.23M | 18.86% | 8,963,500 | 0 | 0.0% | — | Unchanged |
| STOK | STOKE THERAPEUTICS INC | $132.14M | 15.27% | 4,038,404 | -725,269 | -15.2% | -$23.73M | Reduced |
| AGIO | AGIOS PHARMACEUTICALS INC | $126.51M | 14.62% | 3,408,937 | 797,369 | 30.5% | $29.59M | Added |
| CCCC | C4 THERAPEUTICS INC | $34.22M | 3.95% | 7,326,691 | 327,789 | 4.7% | $1.53M | Added |
| KRRO | KORRO BIO INC | $20.27M | 2.34% | 1,538,296 | 0 | 0.0% | — | Unchanged |
| — | TSCAN THERAPEUTICS INC | $7.86M | 0.91% | 8,019,148 | 0 | 0.0% | — | Unchanged |
| DTIL | PRECISION BIOSCIENCES INC | $7.47M | 0.86% | 950,466 | -34,647 | -3.5% | -$272,325 | Reduced |
| — | NEUPHORIA THERAPEUTICS INC | $3.83M | 0.44% | 875,328 | 0 | 0.0% | — | Unchanged |
| — | PASSAGE BIO INC | $3.29M | 0.38% | 673,759 | 50,055 | 8.0% | $244,268 | Added |
| CGON | CG ONCOLOGY INC | $2.23M | 0.26% | 31,391 | -200 | -0.6% | -$14,210 | Reduced |
| — | PLIANT THERAPEUTICS INC | $2.05M | 0.24% | 1,798,070 | 1,798,070 | — | $2.05M | New |
| TRDA | ENTRADA THERAPEUTICS INC | $1.31M | 0.15% | 178,606 | -33,083 | -15.6% | -$243,491 | Reduced |
| — | VYNE THERAPEUTICS INC | $1.06M | 0.12% | 1,628,700 | 0 | 0.0% | — | Unchanged |
| — | PROQR THRAPEUTICS N V | $969,828 | 0.11% | 521,413 | 452,927 | 661.3% | $842,444 | Added |
| — | TRAWS PHARMA INC | $471,801 | 0.05% | 559,470 | 544,392 | 3,610.5% | $459,086 | Added |
| FHTX | FOGHORN THERAPEUTICS INC | $300,549 | 0.03% | 61,588 | 61,588 | — | $300,549 | New |
| DNLI | DENALI THERAPEUTICS INC | $299,844 | 0.03% | 11,658 | -1,868,645 | -99.4% | -$48.06M | Reduced |
| XNCR | XENCOR INC | $292,923 | 0.03% | 18,194 | -518,204 | -96.6% | -$8.34M | Reduced |
| ABSI | ABSCI CORPORATION | $246,230 | 0.03% | 21,245 | 0 | 0.0% | — | Unchanged |
| — | WEREWOLF THERAPEUTICS INC | $236,737 | 0.03% | 657,786 | 0 | 0.0% | — | Unchanged |
| IMTX | IMMATICS N.V | $235,381 | 0.03% | 23,236 | -193,737 | -89.3% | -$1.96M | Reduced |
| AVTX | AVALO THERAPEUTICS INC | $186,648 | 0.02% | 10,100 | 10,100 | — | $186,648 | New |
| — | BOLT BIOTHERAPEUTICS INC | $118,580 | 0.01% | 30,800 | 0 | 0.0% | — | Unchanged |
| NUVB | NUVATION BIO INC | $91,045 | 0.01% | 16,029 | 16,029 | — | $91,045 | New |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | $66,100 | 0.01% | 10,000 | 10,000 | — | $66,100 | New |
| IKT | INHIBIKASE THERAPEUTICS INC | $40,600 | 0.00% | 20,000 | 20,000 | — | $40,600 | New |
| DSGN | DESIGN THERAPEUTICS INC | $0 | 0.00% | 0 | -119,516 | -100.0% | -$1.27M | Sold out |
| — | IBIO INC | $0 | 0.00% | 0 | -68,076 | -100.0% | -$129,344 | Sold out |